SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-282783
Filing Date
2022-11-10
Accepted
2022-11-10 17:12:00
Documents
14
Period of Report
2022-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d407208d8k.htm   iXBRL 8-K 26302
2 EX-99.1 d407208dex991.htm EX-99.1 54171
6 GRAPHIC g407208g1111012858308.jpg GRAPHIC 3305
  Complete submission text file 0001193125-22-282783.txt   216846

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gray-20221110.xsd EX-101.SCH 2846
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gray-20221110_lab.xml EX-101.LAB 18739
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gray-20221110_pre.xml EX-101.PRE 11701
8 EXTRACTED XBRL INSTANCE DOCUMENT d407208d8k_htm.xml XML 3470
Mailing Address 203 REDWOOD SHORES PARKWAY, SUITE 620 REDWOOD CITY CA 94065
Business Address 203 REDWOOD SHORES PARKWAY, SUITE 620 REDWOOD CITY CA 94065 650-487-2800
GRAYBUG VISION, INC. (Filer) CIK: 0001534133 (see all company filings)

IRS No.: 452120079 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39538 | Film No.: 221378507
SIC: 2834 Pharmaceutical Preparations